MXPA01004291A - Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos. - Google Patents
Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.Info
- Publication number
- MXPA01004291A MXPA01004291A MXPA01004291A MXPA01004291A MXPA01004291A MX PA01004291 A MXPA01004291 A MX PA01004291A MX PA01004291 A MXPA01004291 A MX PA01004291A MX PA01004291 A MXPA01004291 A MX PA01004291A MX PA01004291 A MXPA01004291 A MX PA01004291A
- Authority
- MX
- Mexico
- Prior art keywords
- seq
- nos
- chlamydia
- polynucleotide molecules
- encode
- Prior art date
Links
- 241000606161 Chlamydia Species 0.000 title abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 208000007190 Chlamydia Infections Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La presente invencion provee moleculas de polinucleotido purificadas y aisladas que codifican polipeptidos de Chlamydia que se pueden usar en metodos para prevenir, tratar y diagnosticar infeccion por Chlamydia; en una forma de la invencion, las moleculas de polinucleotido se seleccionan de ADN que codifica los polipeptidos CPN100397 (SEQ ID Nos: 1 y 2), CPN100421 (SEQ ID Nos. 3 y 4), CPN100422 (SEQ ID Nos: 4 y 6), CPN100424 (SEQ ID Nos: 7 y 8), CPN10426 (SEQ ID Nos: 9 y 10), CPN100508 (SEQ ID Nos: 11 y 12), CPN100515 (SEQ ID Nos: 13 y 14), CPN100538 (SEQ ID Nos: 15 y 16), CPN100557 (SEQ ID Nos: 17 y 18), CPN100622 (SEQ ID Nos: 19 y 20), CPN100626 (SEQ ID Nos: 21 y 22), CPN100628 (SEQ ID Nos: 23 y 24) y CPN100630 (SEQ ID Nos: 25 y 26).
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10603498P | 1998-10-28 | 1998-10-28 | |
US10604298P | 1998-10-28 | 1998-10-28 | |
US10604498P | 1998-10-28 | 1998-10-28 | |
US10603998P | 1998-10-28 | 1998-10-28 | |
US10607298P | 1998-10-29 | 1998-10-29 | |
US10607498P | 1998-10-29 | 1998-10-29 | |
US10608798P | 1998-10-29 | 1998-10-29 | |
US10607398P | 1998-10-29 | 1998-10-29 | |
US10658998P | 1998-11-02 | 1998-11-02 | |
US10703598P | 1998-11-02 | 1998-11-02 | |
US10658798P | 1998-11-02 | 1998-11-02 | |
US10703498P | 1998-11-02 | 1998-11-02 | |
US10658898P | 1998-11-02 | 1998-11-02 | |
PCT/CA1999/000992 WO2000024765A2 (en) | 1998-10-28 | 1999-10-28 | Chlamydia antigens and corresponding dna fragments and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01004291A true MXPA01004291A (es) | 2003-06-09 |
Family
ID=27584510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA01004291A MXPA01004291A (es) | 1998-10-28 | 1999-10-28 | Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1129202A2 (es) |
JP (1) | JP2002530052A (es) |
CA (1) | CA2348827A1 (es) |
MX (1) | MXPA01004291A (es) |
WO (1) | WO2000024765A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1135501A1 (en) | 1998-12-01 | 2001-09-26 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
US7297341B1 (en) | 1998-12-23 | 2007-11-20 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US6808713B1 (en) | 1998-12-28 | 2004-10-26 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
MXPA01009256A (es) | 1999-03-12 | 2003-07-14 | Aventis Pasteur | Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos. |
ATE375391T1 (de) | 1999-05-03 | 2007-10-15 | Sanofi Pasteur Ltd | Chlamydia-antigene und entsprechende dna- fragmente und deren verwendungen |
WO2001021804A1 (en) | 1999-09-20 | 2001-03-29 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
US7807802B2 (en) | 2002-11-12 | 2010-10-05 | Abbott Lab | Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2264810T3 (es) * | 1997-06-23 | 2007-01-16 | Loke Diagnostics Aps | Proteinas de chlamydia pneumoniae expuestas en la superficie. |
KR20010032336A (ko) * | 1997-11-21 | 2001-04-16 | 브랑디 빠스깔 | 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
-
1999
- 1999-10-28 JP JP2000578335A patent/JP2002530052A/ja active Pending
- 1999-10-28 CA CA002348827A patent/CA2348827A1/en not_active Abandoned
- 1999-10-28 MX MXPA01004291A patent/MXPA01004291A/es unknown
- 1999-10-28 EP EP99955602A patent/EP1129202A2/en not_active Withdrawn
- 1999-10-28 WO PCT/CA1999/000992 patent/WO2000024765A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000024765A3 (en) | 2000-11-09 |
EP1129202A2 (en) | 2001-09-05 |
WO2000024765A2 (en) | 2000-05-04 |
WO2000024765A8 (en) | 2001-12-20 |
CA2348827A1 (en) | 2000-05-04 |
JP2002530052A (ja) | 2002-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2218872T3 (es) | Polipeptido 10 de tipo citoquina de mamifero. | |
EP1005540A4 (en) | IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS | |
IL134042A0 (en) | Modified dorsal tissue affecting factor and compositions | |
IL140937A0 (en) | Molecules designated ldcam | |
AU8881201A (en) | Tnf receptor-like molecules and uses thereof | |
MXPA01004291A (es) | Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos. | |
IL110942A0 (en) | Grb3-3 gene, its variants and their uses | |
MXPA03000979A (es) | Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas. | |
WO2003008441A3 (en) | Moringa seed proteins | |
EP0643719A4 (en) | NUCLEIC ACID SEQUENCES ENCODING NUCLEIC ACID SEQUENCES ENCODING THE INTERLEUKIN-9 RECEPTOR, OR COMPLEMENTARY TO THESE SEQUENCES. | |
DK0773999T3 (da) | OR-1, en orphan-receptor tilhørende kernereceptorfamilien | |
WO2000032794A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
PE20399A1 (es) | Muteina ob | |
ATE318933T1 (de) | Nukleinsäurefragmente zur identifizierung von dechlorierenden bakterien | |
DE59410427D1 (en) | Endothelinkonversionsenzym (ece) | |
MXPA03000980A (es) | Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas. | |
DE69636737D1 (de) | Neues immunoregulatorisches protein lst-1 |